PerkinElmer, China To Collaborate On Personalized Medicine Research
This article was originally published in PharmAsia News
Executive Summary
China's National Center for Drug Screening and U.S.-based PerkinElmer agreed to collaborate in establishing a program for validated biomarkers for personalized medicine research and development.